Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins
Skin cancers are the most common malignancies in the world. Among the most frequent skin cancer entities, squamous cell carcinoma (SCC) ranks second (~20%) after basal cell carcinoma (~77%). In early stages, a complete surgical removal of the affected tissue is carried out as standard therapy. To tr...
Main Authors: | Mirijam Schäfer, Marie Luise Semmler, Thoralf Bernhardt, Tobias Fischer, Vinodh Kakkassery, Robert Ramer, Martin Hein, Sander Bekeschus, Peter Langer, Burkhard Hinz, Steffen Emmert, Lars Boeckmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1770 |
Similar Items
-
A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin <i>N</i>-Glycosides and Indirubin-3′-Monoxime in Plasma and Cell Culture Medium
by: Alica Fischle, et al.
Published: (2022-05-01) -
A Thia-Analogous Indirubin <i>N</i>-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells
by: Franziska Wendt, et al.
Published: (2023-10-01) -
Pharmacological properties of indirubin and its derivatives
by: Lin Yang, et al.
Published: (2022-07-01) -
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents
by: Antonia Efstathiou, et al.
Published: (2018-12-01) -
Inhibition of Suicidal Erythrocyte Death by Indirubin-3’-Monoxime
by: Chunqiu Liu, et al.
Published: (2018-02-01)